akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 51 blog entries.

MHRA Class 2 Medicines Recall: Synalar GEL 30g & Synalar GEL 60g, (fluocinoline acetonide 0.025%) Reig Jofre UK

MHRA Class 2 Medicines Notification: Synalar GEL 30g, Synalar GEL 60g,(fluocinoline acetonide 0.025%) Reig Jofre UK Drug alert number: EL(25)A/16 Date issued: 08 April 2025 It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of [...]

The post MHRA Class 2 Medicines Recall: Synalar GEL 30g & Synalar GEL 60g, (fluocinoline acetonide 0.025%) Reig Jofre UK appeared first on Community Pharmacy England.

By |April 8th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Synalar GEL 30g & Synalar GEL 60g, (fluocinoline acetonide 0.025%) Reig Jofre UK

Cetraxal® preparations – change to special container status from sub-pack to complete pack

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status as complete pack sizes from April 2025: Cetraxal® 2mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) Cetraxal® Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma [...]

The post Cetraxal® preparations – change to special container status from sub-pack to complete pack appeared first on Community Pharmacy England.

By |March 31st, 2025|Lexpos News|Comments Off on Cetraxal® preparations – change to special container status from sub-pack to complete pack

MHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited)

MHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited) Drug alert number: EL(25)A/12 Date issued: 31 March 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, [...]

The post MHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited) appeared first on Community Pharmacy England.

By |March 31st, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Notification: Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension (Cross Healthcare Limited)

Medicine Supply Notification: Megestrol (Megace®) 160mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Megestrol (Megace®) 160mg tablets MSN/2025/016 Tier 2 – medium impact Date of issue: 25/03/2025 Megestrol (Megace®) 160mg tablets are out of stock until mid-April 2025. Medroxyprogesterone (Provera®) 200mg and 400mg tablets remain available and can support an increase in demand. Medroxyprogesterone [...]

The post Medicine Supply Notification: Megestrol (Megace®) 160mg tablets appeared first on Community Pharmacy England.

By |March 25th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Megestrol (Megace®) 160mg tablets

Tax credits are ending – downloadable poster for pharmacies to display

Community pharmacy teams are reminded that, from 6 April 2025, patients who hold a tax credit exemption certificate will no longer receive automatic entitlement to free NHS prescriptions under the ‘Tax Credit exemption certificate’ category. This is because HM Revenue & Customs (HMRC) will be ending tax credit payments on 5 April 2025. To help [...]

The post Tax credits are ending – downloadable poster for pharmacies to display appeared first on Community Pharmacy England.

By |March 21st, 2025|Lexpos News|Comments Off on Tax credits are ending – downloadable poster for pharmacies to display